[go: up one dir, main page]

BR0110034A - Inibidores do transporte de fosfatos - Google Patents

Inibidores do transporte de fosfatos

Info

Publication number
BR0110034A
BR0110034A BR0110034-3A BR0110034A BR0110034A BR 0110034 A BR0110034 A BR 0110034A BR 0110034 A BR0110034 A BR 0110034A BR 0110034 A BR0110034 A BR 0110034A
Authority
BR
Brazil
Prior art keywords
transport inhibitors
phosphate transport
phosphate
sulfonamido
aryl
Prior art date
Application number
BR0110034-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Joseph Weinstock
Gerald Girard
Dimitri Gaitanopoulos
Original Assignee
Smithkline Beecham Corporatiio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporatiio filed Critical Smithkline Beecham Corporatiio
Publication of BR0110034A publication Critical patent/BR0110034A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BR0110034-3A 2000-05-12 2001-05-11 Inibidores do transporte de fosfatos BR0110034A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20399500P 2000-05-12 2000-05-12
PCT/US2001/015324 WO2001087294A1 (en) 2000-05-12 2001-05-11 Phosphate transport inhibitors

Publications (1)

Publication Number Publication Date
BR0110034A true BR0110034A (pt) 2003-05-27

Family

ID=22756167

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110034-3A BR0110034A (pt) 2000-05-12 2001-05-11 Inibidores do transporte de fosfatos

Country Status (14)

Country Link
JP (1) JP2003533477A (es)
KR (1) KR20020093983A (es)
CN (1) CN1429108A (es)
AU (1) AU2001261471A1 (es)
BR (1) BR0110034A (es)
CA (1) CA2408667A1 (es)
CZ (1) CZ20023701A3 (es)
HU (1) HUP0302234A2 (es)
IL (1) IL152587A0 (es)
MX (1) MXPA02011160A (es)
NO (1) NO20025399D0 (es)
PL (1) PL359931A1 (es)
WO (1) WO2001087294A1 (es)
ZA (1) ZA200209106B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2378179A (en) * 2001-08-03 2003-02-05 Pantherix Ltd Aromatic sulfonamides and their use in treating bacterial diseases
US7119120B2 (en) 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
SI2384318T1 (en) 2008-12-31 2018-03-30 Ardelyx, Inc. MEASURES AND PROCEDURES FOR THE INHIBITION OF ANTIPORT INHIBITED BY NHE IN THE TREATMENT OF DISEASES RELATED TO STRENGTH OF FLAMMABILITY OR TRADEMARITY WITH SOLO, AND THE EMISSION OF GASTROINTESTINAL TREATMENT
RU2015107019A (ru) 2012-08-21 2016-10-10 Эрделикс Инк. Соединения и способы для ингибирования nhe-опосредованного антипорта в лечении расстройств, ассоциированных с задержкой жидкости или солевой перегрузкой и заболеваний желудочно-кишечного тракта
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
CN103183623A (zh) * 2013-03-12 2013-07-03 中国医学科学院医药生物技术研究所 一组苯磺酰胺基苯甲酰胺类衍生物及制备和应用
MX382203B (es) 2013-04-12 2025-03-11 Ardelyx Inc Compuestos de union a nhe3 (intercambiador de sodio-hidrogeno 3) y metodos para inhibir transporte de fosfato.
US9765050B2 (en) 2014-12-30 2017-09-19 Novira Therapeutics, Inc. Pyridyl reverse sulfonamides for HBV treatment
CN105395532B (zh) * 2015-11-25 2017-11-14 中国医学科学院医药生物技术研究所 2‑苯磺酰胺基苯甲酰胺类化合物在肝损伤保护和肝纤维化防治中的应用
US10793520B2 (en) 2016-08-30 2020-10-06 Nippon Soda Co., Ltd. Sulfonylaminobenzamide compound and pest control agent
UA126283C2 (uk) 2017-01-09 2022-09-14 Арделікс, Інк. Сполуки, придатні для лікування розладів шлунково-кишкового тракту
JP2020505333A (ja) 2017-01-09 2020-02-20 アルデリックス, インコーポレイテッド Nhe媒介性アンチポートの阻害薬
EP4140991B1 (en) * 2018-06-01 2024-05-15 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1044449A1 (zh) * 1999-06-24 2002-10-25 Smithkline Beecham Corporation 巨噬细胞清除剂受体拮抗剂
CO5190714A1 (es) * 1999-07-20 2002-08-29 Smithkline Beecham Corp Inhibidores del transporte de fosfato

Also Published As

Publication number Publication date
PL359931A1 (en) 2004-09-06
CN1429108A (zh) 2003-07-09
AU2001261471A1 (en) 2001-11-26
CZ20023701A3 (cs) 2003-11-12
CA2408667A1 (en) 2001-11-22
JP2003533477A (ja) 2003-11-11
ZA200209106B (en) 2003-10-23
HUP0302234A2 (hu) 2003-11-28
KR20020093983A (ko) 2002-12-16
MXPA02011160A (es) 2003-03-10
NO20025399L (no) 2002-11-11
NO20025399D0 (no) 2002-11-11
IL152587A0 (en) 2003-05-29
WO2001087294A1 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
TR200200112T2 (tr) Fosfat taşıma ihtibitörleri
BR0110034A (pt) Inibidores do transporte de fosfatos
WO2002028353A3 (en) Phosphate transport inhibitors
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
ES2152196T3 (es) Implante para vertebra.
PT883415E (pt) Inalador para medicacao em po
DE60033025D1 (de) Knochenersatz aus kalziumphosphat
ATE258928T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
BRPI0411924A (pt) métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos
EP1274444A4 (en) COMPOUNDS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS OR DISORDERS CAUSED BY THE ABUSE OF PSYCHOACTIVE SUBSTANCES
ATE259796T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
PT1255538E (pt) Utilizacao do acido 2-metil-tiazolidin-2,4-dicarboxilico e/ou sais compativeis fisiologicamente para tratamento e/ou prevencao de cancros
ES2166816T3 (es) Derivados piridil-imidazolicos y procedimientos para su preparacion.
IL139144A0 (en) Mycobacterial inhibitors
PL367707A1 (en) Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol
PT1212119E (pt) Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas
NO20012777D0 (no) Anvendelse av riluzol ved behandling av akustiske traumer
ATE392213T1 (de) Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen
BR9708037A (pt) Método para o tratamento de abuso de substância
BR9612549A (pt) Método para tratamento de agressão excessiva
EE200200705A (et) Süsteemid ja meetodid limaskesta ravimiseks
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]